Glycaemic efficacy Compared with placebo, tirzepatide 15 mg was the most efficacious treatment in reducing HbA 1c (MD [95% CI]: 21.61 mmol/mol [23.26 to 19.97] [1.96% (2.11 to 1.82)]), followed by tirzepatide 10 mg (20.19 mmol/mol [21.89 to 18.48] [1.84% (1.99 to 1.69)]), semaglutide 2.0 mg (17.74 mmol/mol [22.03 to 13.45] [1.59% (1.95 to 1.22)]), tirzepatide 5 mg (17.60 mmol/mol [19.36 to 15.84] [1.60% (1.75 to 1.44)]), semaglutide 1.0 mg (15.25 mmol/mol [16.73 to 13.77] [1.39% (1.52 to 1.26)]) and semaglutide 0.5 mg (12.00 mmol/mol [13.74 to 10.26] [1.09% (1.24 to 0.94)]) (Fig
However, its important to note that surgical interventions are typically reserved for cases in which cosmetic improvement is desired, not for medical necessity
29 In terms of improving reproductive function, studies have shown that GLP-1RA can reduce total testosterone (T) and free T levels in obese PCOS patients, thereby alleviating hyperandrogenism, improving menstruation, and increasing fertility rates
Solid lipid nanoparticles and liposomes are being extensively investigated as potential therapeutic agents for Alzheimer's and Parkinson's diseases
